![BeardBros_BlogImages [Recovered]](https://beardbrospharms.com/wp-content/uploads/2026/07/BeardBros_BlogImages-Recovered-scaled.png)
In November 2025, the United States government quietly redrew the legal boundaries of the cannabis seed market. The change was buried inside a federal appropriations bill, was dwarfed by the hemp product market reaction, received almost no mainstream attention, and takes full effect on November 12, 2026. For commercial cannabis growers, breeders, home growers, and seed banks & producers, in the US and internationally, it represents one of the most significant regulatory disruptions to starting material access in the history of the legal industry.
Understanding what changed, and what it means for genetic diversity in the US market, is essential for anyone with a stake in where this plant is headed.
What Section 781 Actually Does
Since the 2018 Farm Bill, the legal status of a cannabis seed has been determined by its own chemical composition. Ungerminated seeds contain negligible THC, well below any threshold, so they were treated as legal hemp products. That framework allowed seeds and genetics to move through domestic and international channels with relative clarity, and it enabled a US seed market to develop that gave growers access to a very diverse range of cultivars.
Section 781 of P.L. 119-37, enacted November 12, 2025, eliminates that framework. Under the new definition, a seed’s legal status is no longer determined by what it contains, it’s determined by what the mother plant could produce. Any viable seed from a cannabis plant that would exceed 0.3% total THC (including THCA) is now classified as marijuana under the Controlled Substances Act, regardless of the seed’s own cannabinoid content.
A seed containing zero THC is now a federally controlled substance if its genetic lineage traces to a high-THC mother plant. Interstate transport, importation, and exportation of those seeds become federal crimes as of November 12, 2026.
The Impact on the Market
For international breeders and seed companies that have historically supplied the US market, this is immediate. Seeds that previously cleared US Customs under the 2018 Farm Bill framework now fall outside the new definition of hemp if the source genetics exceed 0.3% total THC. CBP becomes a direct enforcement chokepoint for imports that cleared without issue last year.
For domestic seed bank operators, the interstate commerce wall, already a persistent constraint for licensed cannabis businesses, just got higher. Breeders developing new cultivars, processors seeking specific cannabinoid profiles, and cultivators trying to source better genetics are now operating in a tighter, more legally exposed environment. Critically, restricted genetic access increases the risk of industry-wide crop failure.
A limited cultivar pool reduces resilience against catastrophic events, pathogens, and pests.Section 781 of the Consolidated Appropriations Act, signed into law November 12, 2025, ties a cannabis seed’s federal legal status to the eventual THC content of the plant it produces, and when the rule takes effect in November 2026, seeds, and genetic material that produce flower above the 0.3 percent threshold will be classified as Schedule I controlled substances before they are ever planted. Industry advocates argue that the standard ignores how THC expression actually works in the field, where soil, climate, light cycles, and harvest timing can shift the same seed lot from compliant to noncompliant from one farm to the next.
“We built this company over many years through genuine expertise, and today we employ workers on both sides of the Atlantic as part of a global supply chain that serves the American hemp industry,” said a spokesperson for a major international seedbank. “A little-known provision known as Section 781, now law and set to take effect this November, would impose federal restrictions that classify noncompliant seed as a scheduled drug based on what it might one day grow into, a vague and shifting standard that no legitimate business can plan around.
The consequences reach far beyond our company, threatening the innovation in genetics that American policymakers are counting on to advance building materials, sustainable textiles, and soil remediation. We are confident that once legislators understand the full ramifications, they will act to correct this, and we are committed to being a constructive part of that solution.” Industry groups including the asiga.org have flagged Section 781 as one of the most consequential and least-publicized hemp policy changes of the past decade, and are now pressing congressional offices for a technical correction or delayed implementation before the November deadline.
The Genetic Diversity Problem
This is where it gets serious for the long-term health of the industry. Genetic diversity is the foundation of crop resilience, the difference between a plant base that can adapt to disease pressure, climate variation, and evolving market demands, and one that can’t.
The cannabis plant carries extraordinary genetic diversity. That diversity is the raw material breeders work with to create new cultivars, dial in cannabinoid profiles, and build the starting material that every product on every shelf traces back to. When regulatory architecture restricts which genetics can legally cross state and national borders, diversity doesn’t totally disappear, but access to it consolidates. The legal and compliance costs create a filter that independent and small-scale breeders can’t absorb. Larger operators are more immune, but won’t be out of the woods by any means. The result looks a lot like what happened to corn, soy, and cotton: a narrowing gene pool controlled by a small number of powerful actors.
Beard Bros has written extensively about how Prop 64 was sold as protection for legacy cultivators and delivered the opposite. This is that same playbook running at the federal level, through the seed supply.
What the Farm Bill Didn’t Fix
The 2026 Farm Bill was supposed to be the safety valve. An amendment from Rep. Jim Baird would have delayed the November 2026 implementation date by one year. The House Agriculture Committee declined to advance it. No meaningful extension has been enacted. The clock is running.
The Farm Bill does accommodate industrial hemp growers,food, fiber and grain operators may see looser testing requirements, but the definition changes affecting high-resin genetics and associated seeds remain fully in place. For anyone working with cannabinoid-producing cultivars in a licensed program, the federal landscape has gotten substantially more constrained.
What Has to Happen
This requires federal legislation that treats seeds and genetics as agricultural starting material, not as controlled substances defined by theoretical future THC expression. Clear interstate commerce protections for seeds from compliant cultivars.
The US cannabis seed market is at an inflection point. Trade organizations are working together as a unified front to tackle these challenges. The decisions made in the next few months, in Congress, at the USDA, and potentially in the courts, will determine whether this industry retains the genetic diversity it needs to grow into something durable, or whether it becomes another sector where consolidation was written into the regulatory framework before most people knew what was happening.
The regulatory landscape is now a significant electoral issue. The Congressional stance on cannabis seeds and hemp will profoundly influence voter decisions, and the White House has publicly engaged on this topic. I encourage every operator to join a trade org that aligns with your values, hemp consumers and home growers, many of these same trade organizations provide easy to complete forms that make contacting your elected officials quick and effortless. Donate to campaigns that support regulations instead of bans, hold federal officials accountable, and most importantly vote to protect access.
Saving seeds is only meaningful if the law lets you keep them. Section 781 of H.R. 5371 redefines hemp in a way that pulls viable seed into the federal THC restriction, despite the fact that seeds themselves contain no THC, and that the proposed traceback to mother plant chemistry isn’t implementable in practice. The American Seed Innovation & Growth Alliance has put forward a narrow, common-sense fix: remove the seed language. Anyone interested can review the policy brief and join the coalition at asiga.org. Pushback from inside the industry is already organizing.
ASIGA has stepped forward to coordinate the effort, bringing together breeders, farmers, researchers, and medical-sector operators who say they cannot afford to wait for the November 12, 2026 enforcement date to pass before acting. To fund that work, the group has opened a public campaign on GoFundMe — Save American Hemp & Cannabis Genetics — Deadline Nov 12 — with dollars earmarked for statutory analysis, repeal strategy, lobbying and direct congressional engagement, expert economic impact assessments, and day-to-day coalition operations. The urgency, in ASIGA’s framing, is mathematical rather than rhetorical: there are only so many weeks left before the law takes effect, and undoing the harm afterward will be a far steeper climb than preventing it in the first place.
For cultivators, breeders, and operators who’ve fought to build something real in this industry: this is the regulatory fight worth paying attention to right now.
As a vocal advocate for cannabis genetics, Kasey Kollross champions the industry through high-level trade involvement, legislative campaigning, and direct engagement with operators and retailers.
His advocacy is defined by three primary areas:
High-Level Trade and Legislative Advocacy: As a Board Member for the National Cannabis Industry Association (NCIA), Kollross helps shape operational strategy and advocates on Capitol Hill to protect the legal industry from outdated prohibition-era policies.
Protecting Genetic Access: Kollross is actively combating Section 781 of the federal funding bill, which threatens cannabis’s genetic diversity by redefining seeds based on the mother plant’s THC content. This creates a legally unstable environment for interstate seed trade and risks concentrating genetics into the hands of large corporations. He advocates for federal legislation to treat seeds as agricultural material, not controlled substances, and supports the American Seed Innovation & Growth Alliance (ASIGA) in their efforts to repeal this section.
Ensuring Market Access: Through his role at Natural Harvest, a US-based Seed Bank, Kasey works to provide licensed operators and consumers with compliant, high-quality genetics from renowned breeders. He clarifies compliance frameworks for cultivators and supports the home-grower community.
